Spero Therapeutics (SPRO) Asset Utilization Ratio (2017 - 2026)
Spero Therapeutics' (SPRO) quarterly Asset Utilization Ratio came in at 0.2 in Q1 2026, up 79.37% YoY from 0.11 in Q1 2025, and down 3.88% on a QoQ basis from 0.2 in Q4 2025.
Spero Therapeutics (SPRO) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Spero Therapeutics (SPRO) has 10 years of Asset Utilization Ratio data on file, last reported at 0.2 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 79.37% year-over-year to 0.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.2 (up 79.37% YoY) and the FY2025 annual result came in at 0.14, up 5443.61% from the prior year.
- Asset Utilization Ratio declined to 0.2 in Q1 2026, from 0.2 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.44 in Q3 2023 to a low of 0.16 in Q3 2022.
- A 5-year average of 0.07 and a median of 0.04 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 4339.32% in 2022, down 260.22% in 2022.
- Tracing SPRO's Asset Utilization Ratio over 5 years: stood at 0.2 in 2022, then tumbled by 103.15% to 0.01 in 2023, then soared by 1447.59% to 0.09 in 2024, then jumped by 140.59% to 0.2 in 2025, then slipped by 3.88% to 0.2 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.2 (Q1 2026), 0.2 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13 |
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.10 |
| Mar 31, 2022 | -0.04 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.10 |